
The organization would become more difficult to operate should Novo Nordisk reach its ambition of continuing on its current growth track, which has catapulted the company all the way to the upper echelons as one of the world’s biggest pharmaceutical companies.
”A lot of people probably don’t think about it in everyday life, but Novo Nordisk has actually become one of the world’s biggest pharmaceutical firms. We’re continuing to grow, and if we succeed with our strategy, we will have even more therapeutic areas in a few years,” says Helge Lund, chair of the board at Novo Nordisk, adding:
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app